Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.1	46.33	69.55	34.27	15.75	10.69
Short-Term Investments	-	-	-	-	54.6	54.78
Cash & Short-Term Investments	21.1	46.33	69.55	34.27	70.35	65.47
Cash Growth	-8.11%	-33.38%	102.92%	-51.29%	7.46%	5.57%
Receivables	7.33	0.08	4.42	0.49	-	-
Inventory	2.3	2.46	1.02	-	-	-
Prepaid Expenses	3.59	2.31	2.55	4.36	3.97	2.18
Total Current Assets	36.28	51.18	77.53	39.12	74.33	67.65
Property, Plant & Equipment	1.89	2.58	3.62	5.33	5.5	4.94
Long-Term Deferred Charges	-	-	-	-	-	0.1
Other Long-Term Assets	2.73	0.38	0.45	0.28	0.3	1.47
Total Assets	40.9	54.13	81.6	44.72	80.13	74.15
Accounts Payable	1.59	1.9	2.46	0.51	0.85	0.35
Accrued Expenses	3.88	3.09	8.17	2.43	3.01	2.84
Short-Term Debt	-	-	-	-	41.69	35.32
Current Portion of Long-Term Debt	12.46	12.94	-	-	-	-
Current Portion of Leases	0.7	0.67	0.7	0.3	0.25	0.2
Current Unearned Revenue	1.56	-	-	-	-	0.5
Other Current Liabilities	8.72	10.42	5.69	0.22	0.26	0.28
Total Current Liabilities	28.91	29.01	17.02	3.46	46.06	39.48
Long-Term Debt	21.62	30.98	42.87	-	-	-
Long-Term Leases	0.96	1.35	1.94	1.23	1.47	1.69
Other Long-Term Liabilities	6.45	2.65	-	-	-	-
Total Liabilities	57.94	63.99	61.83	4.69	47.52	41.17
Common Stock	0	0.01	0	0	0	0
Additional Paid-In Capital	299.8	297.16	250.21	203.48	171.6	136.87
Retained Earnings	-316.84	-307.03	-230.45	-163.45	-138.97	-103.89
Comprehensive Income & Other	-	-	-	-	-0.03	0
Total Common Equity	-17.04	-9.86	19.76	40.03	32.61	32.99
Shareholders' Equity	-17.04	-9.86	19.76	40.03	32.61	32.99
Total Liabilities & Equity	40.9	54.13	81.6	44.72	80.13	74.15
Total Debt	35.74	45.94	45.51	1.53	43.41	37.21
Net Cash (Debt)	-14.64	0.39	24.04	32.75	26.95	28.26
Net Cash Growth	-	-98.38%	-26.60%	21.53%	-4.67%	-54.29%
Net Cash Per Share	-1.66	0.08	5.30	9.59	9.96	11.31
Filing Date Shares Outstanding	9.49	9.18	4.24	4.19	2.75	2.54
Total Common Shares Outstanding	9.49	9.18	4.24	4.11	2.75	2.54
Working Capital	7.37	22.17	60.51	35.66	28.27	28.18
Book Value Per Share	-1.80	-1.07	4.66	9.74	11.85	12.97
Tangible Book Value	-17.04	-9.86	19.76	40.03	32.61	32.99
Tangible Book Value Per Share	-1.80	-1.07	4.66	9.74	11.85	12.97
Machinery	1.21	1.79	2.17	2	1.37	0.27
Construction In Progress	-	-	-	2.54	2.73	2.86
Leasehold Improvements	0.05	0.05	0.05	0.05	0.05	0.1

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q